Deya Corzo

1.5k total citations
10 papers, 322 citations indexed

About

Deya Corzo is a scholar working on Oncology, Physiology and Rheumatology. According to data from OpenAlex, Deya Corzo has authored 10 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Physiology and 2 papers in Rheumatology. Recurrent topics in Deya Corzo's work include Lysosomal Storage Disorders Research (3 papers), Glycogen Storage Diseases and Myoclonus (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Deya Corzo is often cited by papers focused on Lysosomal Storage Disorders Research (3 papers), Glycogen Storage Diseases and Myoclonus (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Deya Corzo collaborates with scholars based in United States, Netherlands and Italy. Deya Corzo's co-authors include Mislen Bauer, Nancy D. Leslie, Claire Morgan, John Clancy, Tara O’Meara, Hanna Mandel, Daniel Gruskin, Michael Beck, Susan Richards and Rossella Parini and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Deya Corzo

10 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deya Corzo United States	6	223	145	68	62	56	10	322
J.H.J. Wokke Netherlands	7	303 1.4×	240 1.7×	68 1.0×	79 1.3×	98 1.8×	15	530
A. van der Ploeg Netherlands	5	220 1.0×	175 1.2×	36 0.5×	68 1.1×	55 1.0×	11	292
C. Iturriaga Spain	8	195 0.9×	49 0.3×	57 0.8×	64 1.0×	188 3.4×	8	464
Helena Jahnová Czechia	10	381 1.7×	65 0.4×	40 0.6×	63 1.0×	191 3.4×	18	545
N. Strigl‐Pill Germany	6	361 1.6×	309 2.1×	103 1.5×	92 1.5×	65 1.2×	7	456
Miriam Nickel Germany	12	257 1.2×	99 0.7×	15 0.2×	22 0.4×	119 2.1×	38	385
M. Sévin France	4	221 1.0×	66 0.5×	89 1.3×	62 1.0×	72 1.3×	9	366
Lucía Schottlaender United Kingdom	10	78 0.3×	58 0.4×	87 1.3×	20 0.3×	129 2.3×	15	437
M.G.E.M. Ausems Netherlands	4	333 1.5×	290 2.0×	46 0.7×	122 2.0×	78 1.4×	4	404
Mónica Cozar Spain	12	179 0.8×	51 0.4×	13 0.2×	45 0.7×	113 2.0×	24	369

Countries citing papers authored by Deya Corzo

Since Specialization

Citations

This map shows the geographic impact of Deya Corzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deya Corzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deya Corzo more than expected).

Fields of papers citing papers by Deya Corzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deya Corzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deya Corzo. The network helps show where Deya Corzo may publish in the future.

Co-authorship network of co-authors of Deya Corzo

This figure shows the co-authorship network connecting the top 25 collaborators of Deya Corzo. A scholar is included among the top collaborators of Deya Corzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deya Corzo. Deya Corzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Anderson, Richard A., Ruth Thieroff‐Ekerdt, Malcolm Boyce, et al.. (2020). Pharmacodynamic Activity of the Novel Neurokinin-3 Receptor Antagonist SJX-653 in Healthy Men. The Journal of Clinical Endocrinology & Metabolism. 105(12). e4857–e4865. 12 indexed citations

Makino, Elina, et al.. (2020). Preclinical development of SIG-005 for treatment of MPS I. Molecular Genetics and Metabolism. 129(2). S50–S50. 1 indexed citations

Carmona, Guillaume, Lauren E. Barney, Jared Allan Sewell, et al.. (2019). Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living TherapeuticsTM Products. Blood. 134(Supplement_1). 2065–2065. 7 indexed citations

Leebeek, Frank W.G., Marco J.D. Tangelder, Karina Meijer, et al.. (2016). Interim Results from a Dose Escalating Study of AMT-060 (AAV5-hFIX) Gene Transfer in Adult Patients with Severe Hemophilia B. Blood. 128(22). 2314–2314. 7 indexed citations

Force, Rex W., et al.. (2013). Differences between taxanes in time on therapy and associated discontinuation events in metastatic breast cancer: Results from a U.S. claims analysis.. Journal of Clinical Oncology. 31(26_suppl). 158–158. 1 indexed citations

Kishnani, Priya S., Deya Corzo, Nancy D. Leslie, et al.. (2009). Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease. Pediatric Research. 66(3). 329–335. 232 indexed citations

Ploeg, A. van der, Deya Corzo, J. Florence, et al.. (2009). 96. Placebo-controlled study of alglucosidase alfa in adults with pompe disease. Clinical Neurophysiology. 120(2). e116–e117. 1 indexed citations

Laforêt, Pascal, Deya Corzo, Diana M. Escolar, et al.. (2008). T.O.4 Safety and efficacy results from a randomized, double-blind, placebo-controlled study of alglucosidase alfa for the treatment of Pompe disease in juveniles and adults. Neuromuscular Disorders. 18(9-10). 832–833. 5 indexed citations

Alvarez, X.A., et al.. (1997). Citicoline improves memory performance in elderly subjects.. PubMed. 19(3). 201–10. 53 indexed citations

10.

Alvarez, X.A., et al.. (1997). Citicoline improves memory in elderly subjects. Biological Psychiatry. 42(1). 95S–95S. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact